These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16422308)

  • 21. Sample size determination for three-level randomized clinical trials with randomization at the first or second level.
    Fazzari MJ; Kim MY; Heo M
    J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential boundaries approach in clinical trials with unequal allocation ratios.
    Jafari P; Ayatollahi SM; Behboodian J
    BMC Med Res Methodol; 2006 Jan; 6():1. PubMed ID: 16412232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methodological considerations on the design and analysis of an equivalence stratified cluster randomization trial.
    Piaggio G; Carroli G; Villar J; Pinol A; Bakketeig L; Lumbiganon P; Bergsjø P; Al-Mazrou Y; Ba'aqeel H; Belizán JM; Farnot U; Berendes H;
    Stat Med; 2001 Feb; 20(3):401-16. PubMed ID: 11180310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
    Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
    Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing completely and stratified randomized designs in cluster randomized trials when the stratifying factor is cluster size: a simulation study.
    Lewsey JD
    Stat Med; 2004 Mar; 23(6):897-905. PubMed ID: 15027079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing denominator degrees of freedom approximations for the generalized linear mixed model in analyzing binary outcome in small sample cluster-randomized trials.
    Li P; Redden DT
    BMC Med Res Methodol; 2015 Apr; 15():38. PubMed ID: 25899170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Likelihood inference on the relative risk in split-cluster designs.
    Shoukri MM; Colak D; Donner A
    Clin Trials; 2011 Feb; 8(1):37-47. PubMed ID: 21335588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restricted randomization of ZAMSTAR: a 2 x 2 factorial cluster randomized trial.
    Sismanidis C; Moulton LH; Ayles H; Fielding K; Schaap A; Beyers N; Bond G; Godfrey-Faussett P; Hayes R
    Clin Trials; 2008; 5(4):316-27. PubMed ID: 18697846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confidence intervals for a difference between lognormal means in cluster randomization trials.
    Poirier J; Zou GY; Koval J
    Stat Methods Med Res; 2017 Apr; 26(2):598-614. PubMed ID: 25267552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracluster correlation adjustments to maintain power in cluster trials for binary outcomes.
    Chakraborty H; Moore J; Hartwell TD
    Contemp Clin Trials; 2009 Sep; 30(5):473-80. PubMed ID: 19386285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of community-based cluster randomization trials with binary outcomes.
    Darlington GA; Donner A
    Clin Trials; 2007; 4(5):491-8. PubMed ID: 17942465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Information growth for sequential monitoring of clinical trials with a stepped wedge cluster randomized design and unknown intracluster correlation.
    Brown SP; Shoben AB
    Clin Trials; 2020 Apr; 17(2):176-183. PubMed ID: 32026713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.
    Heritier S; Lô SN; Morgan CC
    Stat Med; 2011 Jun; 30(13):1541-54. PubMed ID: 21432887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of consent practices in cluster randomized trials: improvements are needed in ethical conduct and reporting.
    Taljaard M; Chaudhry SH; Brehaut JC; Weijer C; Boruch R; Donner A; Eccles MP; McRae AD; Saginur R; Zwarenstein M; Grimshaw JM
    Clin Trials; 2014 Feb; 11(1):60-9. PubMed ID: 24346609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
    Thall P; Fox P; Wathen J
    Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the efficiency of estimation in randomized trials of adaptive treatment strategies.
    Lavori PW; Dawson R
    Clin Trials; 2007; 4(4):297-308. PubMed ID: 17848491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and analysis of stepped wedge cluster randomized trials.
    Hussey MA; Hughes JP
    Contemp Clin Trials; 2007 Feb; 28(2):182-91. PubMed ID: 16829207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.